American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 35(Suppl 1), S64–S71 (2012).
Galicia-Garcia, U. et al. Pathophysiology of type 2 diabetes mellitus. Int J. Mol. Sci. 21, E6275 (2020).
Graves, D. T., Ding, Z. & Yang, Y. The impact of diabetes on periodontal diseases. Periodontol 2000 82, 214–224 (2020).
Tang, D. et al. Is hyperglycemia the only risk factor for implant in type 2 diabetics during the healing period? Oral. Dis. 27, 1551–1563 (2021).
Zhang, J. et al. Genipin and insulin combined treatment improves implant osseointegration in type 2 diabetic rats. J. Orthop. Surg. Res. 16, 59 (2021).
Sundar, G. et al. Impact of well-controlled type 2 diabetes mellitus on implant stability and bone biomarkers. Int J. Oral. Maxillofac. Implants 34, 1441–1449 (2019).
Akintoye, S. O. et al. Skeletal site-specific characterization of orofacial and iliac crest human bone marrow stromal cells in same individuals. Bone 38, 758–768 (2006).
Chen, Z. et al. Tuning chemistry and topography of nanoengineered surfaces to manipulate immune response for bone regeneration applications. ACS Nano 11, 4494–4506 (2017).
Sun, R. et al. Effects of metformin on the osteogenesis of alveolar BMSCs from diabetic patients and implant osseointegration in rats. Oral. Dis. 28, 1170–1180 (2022).
Li, J., Liu, C. Y., Jiang, Y. F., Wei, X. Z. & Li, J. U. Proliferation and differentiation of human osteoblasts from a type 2 diabetic patient in vitro. Genet. Mol. Res. 14, 11292–11299 (2015).
Hu, Y. & Zhao, X. Role of m6A in osteoporosis, arthritis and osteosarcoma (Review). Exp. Ther. Med. 22, 926 (2021).
Jiang, H. et al. Transcriptome-wide high-throughput m6A sequencing of differential m6A methylation patterns in the human rheumatoid arthritis fibroblast-like synoviocytes cell line MH7A. J. Inflamm. Res. 14, 575–586 (2021).
Oerum, S., Meynier, V., Catala, M. & Tisné, C. A comprehensive review of m6A/m6Am RNA methyltransferase structures. Nucleic Acids Res. 49, 7239–7255 (2021).
Han, X., Guo, J. & Fan, Z. Interactions between m6A modification and miRNAs in malignant tumors. Cell Death Dis. 12, 598 (2021).
Shen, F. et al. Decreased N(6)-methyladenosine in peripheral blood RNA from diabetic patients is associated with FTO expression rather than ALKBH5. J. Clin. Endocrinol. Metab. 100, E148–E154 (2015).
Liang, D. et al. m6A reader YTHDC1 modulates autophagy by targeting SQSTM1 in diabetic skin. Autophagy 18, 1318–1337 (2022).
Liu, T. et al. The m6A “reader” YTHDF1 promotes osteogenesis of bone marrow mesenchymal stem cells through translational control of ZNF839. Cell Death Dis. 12, 1078 (2021).
Li, Z. et al. The N6-methyladenosine demethylase ALKBH5 negatively regulates the osteogenic differentiation of mesenchymal stem cells through PRMT6. Cell Death Dis. 12, 578 (2021).
Zhou, J., Wei, T. & He, Z. ADSCs enhance VEGFR3-mediated lymphangiogenesis via METTL3-mediated VEGF-C m6A modification to improve wound healing of diabetic foot ulcers. Mol. Med. 27, 146 (2021).
Szklarczyk, D. et al. The STRING database in 2017: Quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 45, D362–D368 (2017).
Perry, R. P., Kelley, D. E., Friderici, K. & Rottman, F. The methylated constituents of L cell messenger RNA: Evidence for an unusual cluster at the 5′ terminus. Cell 4, 387–394 (1975).
Zaccara, S., Ries, R. J. & Jaffrey, S. R. Reading, writing and erasing mRNA methylation. Nat. Rev. Mol. Cell Biol. 20, 608–624 (2019).
Garcia-Campos, M. A. et al. Deciphering the ‘m6A code’ via antibody-independent quantitative profiling. Cell 178, 731–747.e16 (2019).
Zhang, Z. et al. Single-base mapping of m6A by an antibody-independent method. Sci. Adv. 5, eaax0250 (2019).
Ma, H. et al. N6-methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation. Nat. Chem. Biol. 15, 88–94 (2019).
Zhou, J. et al. Dynamic m(6)A mRNA methylation directs translational control of heat shock response. Nature 526, 591–594 (2015).
Choi, J. et al. N(6)-methyladenosine in mRNA disrupts tRNA selection and translation-elongation dynamics. Nat. Struct. Mol. Biol. 23, 110–115 (2016).
Huang, M. et al. m6A methylation regulates osteoblastic differentiation and bone remodeling. Front Cell Dev. Biol. 9, 783322 (2021).
Yang, L. et al. Nsun4 and Mettl3 mediated translational reprogramming of Sox9 promotes BMSC chondrogenic differentiation. Commun. Biol. 5, 495 (2022).
Tian, C., Huang, Y., Li, Q., Feng, Z. & Xu, Q. Mettl3 regulates osteogenic differentiation and alternative splicing of Vegfa in bone marrow mesenchymal stem cells. Int J. Mol. Sci. 20, E551 (2019).
Zheng, J. et al. Identification of MDM2, YTHDF2 and DDX21 as potential biomarkers and targets for treatment of type 2 diabetes. Biochem. Biophys. Res. Commun. 581, 110–117 (2021).
Yao, Y. et al. METTL3 inhibits BMSC adipogenic differentiation by targeting the JAK1/STAT5/C/EBPβ pathway via an m6A-YTHDF2-dependent manner. FASEB J. 33, 7529–7544 (2019).
Du, R., Bai, Y. & Li, L. Biological networks in gestational diabetes mellitus: insights into the mechanism of crosstalk between long non-coding RNA and N6-methyladenine modification. BMC Pregnancy Childbirth 22, 384 (2022).
An, Y. & Duan, H. The role of m6A RNA methylation in cancer metabolism. Mol. Cancer 21, 14 (2022).
Louvanto, K. et al. Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16. Int J. Cancer 136, E638–E645 (2015).
Lorincz, A. T. et al. Methylation of HPV and a tumor suppressor gene reveals anal cancer and precursor lesions. Oncotarget 8, 50510–50520 (2017).
Giuliano, A. R. et al. Methylation of HPV 16 and EPB41L3 in oral gargles: Associations with oropharyngeal cancer detection and tumor characteristics. Int J. Cancer 146, 1018–1030 (2020).
Xie, Y. et al. ADNP prompts the cisplatin-resistance of bladder cancer via TGF-β-mediated epithelial-mesenchymal transition (EMT) pathway. J. Cancer 12, 5114–5124 (2021).
Mollinedo, P. et al. Cellular and animal models of skin alterations in the autism-related ADNP syndrome. Sci. Rep. 9, 736 (2019).
Idan-Feldman, A. et al. Davunetide (NAP) as a preventative treatment for central nervous system complications in a diabetes rat model. Neurobiol. Dis. 44, 327–339 (2011).
Leker, R. R. et al. NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death. Stroke 33, 1085–1092 (2002).
D’Amico, A. G. et al. Nap interferes with hypoxia-inducible factors and VEGF expression in retina of diabetic rats. J. Mol. Neurosci. 61, 256–266 (2017).
D’Amico, A. G. et al. NAP counteracts hyperglycemia/hypoxia induced retinal pigment epithelial barrier breakdown through modulation of HIFs and VEGF expression. J. Cell Physiol. 233, 1120–1128 (2018).
Sethy, N. K., Sharma, N. K., Das, M. & Bhargava, K. Protein profiling reveals antioxidant and signaling activities of NAP (davunetide) in rodent hippocampus exposed to hypobaric hypoxia. J. Mol. Neurosci. 54, 414–429 (2014).
Maugeri, G. et al. Activity-dependent neuroprotective protein (ADNP)-derived peptide (NAP) counteracts UV-B radiation-induced ROS Formation in corneal epithelium. Antioxidants 11, 128 (2022).
Escher, U. et al. Anti-inflammatory effects of the octapeptide NAP in human microbiota-associated mice suffering from subacute ileitis. Eur. J. Microbiol Immunol. 8, 34–40 (2018).
Nakashima, M., Toyono, T., Akamine, A. & Joyner, A. Expression of growth/differentiation factor 11, a new member of the BMP/TGFbeta superfamily during mouse embryogenesis. Mech. Dev. 80, 185–189 (1999).
Qi, X. et al. Endogenous GDF11 regulates odontogenic differentiation of dental pulp stem cells. J. Cell Mol. Med 24, 11457–11464 (2020).
Nakashima, M. et al. Induction of reparative dentin formation by ultrasound-mediated gene delivery of growth/differentiation factor 11. Hum. Gene Ther. 14, 591–597 (2003).
Nakashima, M. et al. Stimulation of reparative dentin formation by ex vivo gene therapy using dental pulp stem cells electrotransfected with growth/differentiation factor 11 (Gdf11). Hum. Gene Ther. 15, 1045–1053 (2004).
Nakashima, M., Mizunuma, K., Murakami, T. & Akamine, A. Induction of dental pulp stem cell differentiation into odontoblasts by electroporation-mediated gene delivery of growth/differentiation factor 11 (Gdf11). Gene Ther. 9, 814–818 (2002).
Li, H. et al. GDF11 attenuates development of Type 2 diabetes via improvement of islet β-cell function and survival. Diabetes 66, 1914–1927 (2017).
Walker, R. G. et al. Exogenous GDF11, but not GDF8, reduces body weight and improves glucose homeostasis in mice. Sci. Rep. 10, 4561 (2020).
留言 (0)